|
1
|
Jankowski J, Floege J, Fliser D, Böhm M
and Marx N: Cardiovascular disease in chronic kidney disease.
Circulation. 143:1157–1172. 2021.
|
|
2
|
Foley RN, Parfrey PS and Sarnak MJ:
Clinical epidemiology of cardiovascular disease in chronic renal
disease. Am J Kidney Dis. 32:S112–S119. 1998.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Allison MA, Hsi S, Wassel CL, Morgan C, Ix
JH, Wright CM and Criqui MH: Calcified atherosclerosis in different
vascular beds and the risk of mortality. Arteriosclerosis Thromb
Vasc Biol. 32:140–146. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Goodman WG, Goldin J, Kuizon BD, Yoon C,
Gales B, Sider D, Wang Y, Chung J, Emerick A and Greaser L:
Coronary-artery calcification in young adults with end-stage renal
disease who are undergoing dialysis. New Engl J Med. 342:1478–1483.
2000.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Liabeuf S, Desjardins L, Diouf M, Temmar
M, Renard C, Choukroun G and Massy ZA: The addition of vascular
calcification scores to traditional risk factors improves
cardiovascular risk assessment in patients with chronic kidney
disease. PLoS One. 10(e0131707)2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hutcheson JD and Goettsch C:
Cardiovascular calcification heterogeneity in chronic kidney
disease. Circul Res. 132:993–1012. 2023.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Heiss A, DuChesne A, Denecke B, Grötzinger
J, Yamamoto K, Renné T and Jahnen-Dechent W: Structural basis of
calcification inhibition by alpha 2-HS glycoprotein/fetuin-A.
Formation of colloidal calciprotein particles. J Biol Chem.
278:13333–13341. 2003.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Schäfer C, Heiss A, Schwarz A, Westenfeld
R, Ketteler M, Floege J, Muller-Esterl W, Schinke T and
Jahnen-Dechent W: The serum protein alpha 2-Heremans-Schmid
glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic
calcification. J Clin Invest. 112:357–366. 2003.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Iyemere VP, Proudfoot D, Weissberg PL and
Shanahan CM: Vascular smooth muscle cell phenotypic plasticity and
the regulation of vascular calcification. J Intern Med.
260:192–210. 2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Luo G, Ducy P, McKee MD, Pinero GJ, Loyer
E, Behringer RR and Karsenty G: Spontaneous calcification of
arteries and cartilage in mice lacking matrix GLA protein. Nature.
386:78–81. 1997.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Schurgers LJ, Cranenburg ECM and Vermeer
C: Matrix Gla-protein: The calcification inhibitor in need of
vitamin K. Thromb Haemost. 100:593–603. 2017.PubMed/NCBI
|
|
12
|
Kumric M, Borovac JA, Kurir TT, Martinovic
D, Separovic IF, Baric L and Bozic J: Role of matrix gla protein in
the complex network of coronary artery disease: A comprehensive
review. Life (Basel). 11(737)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Stenvinkel P, Wang K, Qureshi AR, Axelsson
J, Pecoits-Filho R, Gao P, Barany P, Lindholm B, Jogestrand T,
Heimbürger O, et al: Low fetuin-A levels are associated with
cardiovascular death: Impact of variations in the gene encoding
fetuin. Kidney Int. 67:2383–2392. 2005.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ketteler M, Bongartz P, Westenfeld R,
Wildberger JE, Mahnken AH, Böhm R, Metzger T, Wanner C,
Jahnen-Dechent W and Floege J: Association of low fetuin-A (AHSG)
concentrations in serum with cardiovascular mortality in patients
on dialysis: A cross-sectional study. Lancet. 361:827–833.
2003.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Schurgers LJ, Barreto DV, Barreto FC,
Liabeuf S, Renard C, Magdeleyns EJ, Vermeer C, Choukroun G and
Massy ZA: The circulating inactive form of matrix Gla protein is a
surrogate marker for vascular calcification in chronic kidney
disease. Clin J Am Soc Nephrol. 5:568–575. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Fain ME, Kapuku GK, Paulson WD, Williams
CF, Raed A, Dong Y, Knapen MHJ, Vermeer C and Pollock NK: Inactive
matrix gla protein, arterial stiffness, and endothelial function in
african american hemodialysis patients. Am J Hypertension.
31:735–741. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lin YH, Lin MH, Shi CS, Lin YS, Lin CL,
Yang YH, Liao YS, Chen MY, Tsai MH and Lin MS: The impact of
fetuin-A on predicting aortic arch calcification: Secondary
analysis of a community-based survey. Front Cardiovasc Med.
11(1415438)2024.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Jirak P, Mirna M, Wernly B, Paar V, Thieme
M, Betge S, Franz M, Hoppe U, Lauten A, Kammler J, et al: Analysis
of novel cardiovascular biomarkers in patients with peripheral
artery disease. Minerva Med. 109:443–450. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ix JH, Barrett-Connor E, Wassel CL,
Cummins K, Bergstrom J, Daniels LB and Laughlin GA: The
associations of fetuin-A with subclinical cardiovascular disease in
community-dwelling persons. J Am Coll Cardiol. 58:2372–2379.
2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Aroner SA, St-Jules DE, Mukamal KJ, Katz
R, Shlipak MG, Criqui MH, Kestenbaum B, Siscovick DS, de Boer IH,
Jenny NS, et al: Fetuin-A, glycemic status, and risk of
cardiovascular disease: The multi-ethnic study of atherosclerosis.
Atherosclerosis. 248:224–229. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cahalane RM, Barrett HE, Ross AM,
Mulvihill JJE, Purtill H, Selvarajah L, O'Brien J, Kavanagh EG,
Moloneye MA, Egan SM, et al: On the association between circulating
biomarkers and atherosclerotic calcification in a cohort of
arterial disease participants. Nutr Metab Cardiovasc Dis.
31:1533–1541. 2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Laugsand LE, Ix JH, Bartz TM, Djousse L,
Kizer JR, Tracy RP, Dehghan A, Rexrode K, Lopez OL, Rimm EB, et al:
Fetuin-A and risk of coronary heart disease: A Mendelian
randomization analysis and a pooled analysis of AHSG genetic
variants in 7 prospective studies. Atherosclerosis. 243:44–52.
2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Roos M, von Eynatten M, Heemann U,
Rothenbacher D, Brenner H and Breitling LP: Serum fetuin-A,
cardiovascular risk factors, and six-year follow-up outcome in
patients with coronary heart disease. Am J Cardiol. 105:1666–1672.
2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Akin F, Celik O, Altun I, Ayca B, Diker
VO, Satılmıs S and Sahin C: Relationship of fibroblast growth
factor 23 and fetuin-A to coronary atherosclerosis. J Diabetes
Complications. 29:550–555. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Mohamed ON, Mohamed MRM, Hassan IG,
Alakkad AF, Othman A, Setouhi A and Issa AS: The relationship of
fetuin-A with coronary calcification, carotid atherosclerosis, and
mortality risk in non-dialysis chronic kidney disease. J Lipid
Atheroscler. 13:194–211. 2024.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Pertosa G, Simone S, Ciccone M, Porreca S,
Zaza G, Dalfino G, Memoli B, Procino A, Bonomini M, Sirolli V, et
al: Serum Fetuin A in hemodialysis: A link between derangement of
calcium-phosphorus homeostasis and progression of atherosclerosis?
Am J Kidney Dis. 53:467–474. 2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Hermans MMH, Brandenburg V, Ketteler M,
Kooman JP, van der Sande FM, Boeschoten EW, Leunissen KM, Krediet
RT and Dekker FW: Netherlands cooperative study on the adequacy of
Dialysis (NECOSAD). Association of serum fetuin-A levels with
mortality in dialysis patients. Kidney Int. 72:202–207.
2007.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Pateinakis P, Papagianni A, Douma S,
Efstratiadis G and Memmos D: Associations of fetuin-A and
osteoprotegerin with arterial stiffness and early atherosclerosis
in chronic hemodialysis patients. BMC Nephrol.
14(122)2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chen HY, Chiu YL, Hsu SP, Pai MF, Yang JY
and Peng YS: Low serum fetuin A levels and incident stroke in
patients with maintenance haemodialysis. Eur J Clin Invest.
43:387–396. 2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Pencak P, Czerwieńska B, Ficek R, Wyskida
K, Kujawa-Szewieczek A, Olszanecka-Glinianowicz M, Więcek A and
Chudek J: Calcification of coronary arteries and abdominal aorta in
relation to traditional and novel risk factors of atherosclerosis
in hemodialysis patients. BMC Nephrol. 14(10)2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Collado S, Coll E, Nicolau C, Azqueta M,
Pons M, Cruzado JM, de la Torre B, Deulofeu R, Mojal S, Pascual J
and Cases A: Serum osteoprotegerin in prevalent hemodialysis
patients: Associations with mortality, atherosclerosis and cardiac
function. BMC Nephrol. 18(290)2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ossareh S, Rayatnia M, Vahedi M, Jafari H
and Zebarjadi M: Association of serum fetuin-A with vascular
calcification in hemodialysis patients and its' impact on 3-year
mortality. Iran J Kidney Dis. 14:500–509. 2020.PubMed/NCBI
|
|
33
|
Willeit K, Santer P, Tschiderer L,
Pechlaner R, Vermeer C, Willeit J and Kiechl S: Association of
desphospho-uncarboxylated matrix gla protein with incident
cardiovascular disease and all-cause mortality: Results from the
prospective Bruneck Study. Atherosclerosis. 353:20–27.
2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Virmani R, Burke AP, Farb A and Kolodgie
FD: Pathology of the unstable plaque. Prog Cardiovasc Dis.
44:349–356. 2002.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Mayer O, Seidlerová J, Bruthans J,
Filipovský J, Timoracká K, Vaněk J, Cerná L, Wohlfahrt P, Cífková
R, Theuwissen E and Vermeer C: Desphospho-uncarboxylated matrix
Gla-protein is associated with mortality risk in patients with
chronic stable vascular disease. Atherosclerosis. 235:162–168.
2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Berlot AA, Fu X, Shea MK, Tracy R, Budoff
M, Kim RS, Naveed M, Booth SL, Kizer JR and Bortnick AE: Matrix Gla
protein and the long-term incidence and progression of coronary
artery and aortic calcification in the multi-ethnic study of
atherosclerosis. Atherosclerosis. 392(117505)2024.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Bilalic A, Kurir TT, Kumric M, Borovac JA,
Matetic A, Supe-Domic D and Bozic J: Circulating levels of
dephosphorylated-uncarboxylated matrix gla protein in patients with
acute coronary syndrome. Molecules. 26(1108)2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Shea MK, Booth SL, Weiner DE, Brinkley TE,
Kanaya AM, Murphy RA, Simonsick EM, Wassel CL, Vermeer C and
Kritchevsky SB: Health ABC Study. Circulating vitamin K Is
inversely associated with incident cardiovascular disease risk
among those treated for hypertension in the health, aging, and body
composition study (Health ABC). J Nutr. 147:888–895.
2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Liu YP, Gu YM, Thijs L, Knapen MH, Salvi
E, Citterio L, Petit T, Carpini SD, Zhang Z, Jacobs L, et al:
Inactive matrix gla protein is causally related to adverse health
outcomes. Hypertension. 65:463–470. 2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zwakenberg SR, Burgess S, Sluijs I,
Weiderpass E, Beulens JWJ and van der Schouw YT: Circulating
phylloquinone, inactive Matrix Gla protein and coronary heart
disease risk: A two-sample mendelian randomization study. Clin
Nutr. 39:1131–1136. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Berlot AA, Fu X, Shea MK, Tracy R, Budoff
M, Kim RS, Naveed M, Booth SL, Kizer JR and Bortnick AE: Inactive
matrix gla protein and cardiovascular outcomes: The multi-ethnic
study of atherosclerosis. J Am Heart Assoc.
14(e036459)2025.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Delanaye P, Krzesinski JM, Warling X,
Moonen M, Smelten N, Médart L, Pottel H and Cavalier E:
Dephosphorylated-uncarboxylated Matrix Gla protein concentration is
predictive of vitamin K status and is correlated with vascular
calcification in a cohort of hemodialysis patients. BMC Nephrol.
15(145)2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Jaminon AMG, Dai L, Qureshi AR, Evenepoel
P, Ripsweden J, Söderberg M, Witasp A, Olauson H, Schurgers LJ and
Stenvinkel P: Matrix Gla protein is an independent predictor of
both intimal and medial vascular calcification in chronic kidney
disease. Sci Rep. 10(6586)2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Dai L, Li L, Erlandsson H, Jaminon AMG,
Qureshi AR, Ripsweden J, Brismar TB, Witasp A, Heimbürger O,
Jørgensen HS, et al: Functional vitamin K insufficiency, vascular
calcification and mortality in advanced chronic kidney disease: A
cohort study. PLoS One. 16(e0247623)2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Fitzpatrick J, Kim ED, Sozio SM, Jaar BG,
Estrella MM, Monroy-Trujillo JM and Parekh RS: Calcification
biomarkers, subclinical vascular disease, and mortality among
multiethnic dialysis patients. Kidney Int Rep. 5:1729–1737.
2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Shea MK, Wang J, Barger K, Weiner DE,
Townsend RR, Feldman HI, Rosas SE, Chen J, He J, Flack J, et al:
Association of vitamin K status with arterial calcification and
stiffness in chronic kidney disease: The chronic renal
insufficiency cohort. Curr Dev Nutr. 7(100008)2023.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Shea MK, Barger K, Booth SL, Wang J,
Feldman HI, Townsend RR, Chen J, Flack J, He J, Jaar BG, et al:
Vitamin K status, all-cause mortality, and cardiovascular disease
in adults with chronic kidney disease: The chronic renal
insufficiency cohort. Am J Clin Nutr. 115:941–948. 2022.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Schlieper G, Westenfeld R, Krüger T,
Cranenburg EC, Magdeleyns EJ, Brandenburg VM, Djuric Z, Damjanovic
T, Ketteler M, Vermeer C, et al: Circulating nonphosphorylated
carboxylated matrix gla protein predicts survival in ESRD. J Am Soc
Nephrol. 22:387–395. 2011.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Gluba-Brzózka A, Michalska-Kasiczak M,
Franczyk-Skóra B, Nocuń M, Banach M and Rysz J: Markers of
increased cardiovascular risk in patients with chronic kidney
disease. Lipids Health Dis. 13(135)2014.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Mao L, Huang H, Zhou M and Zhou C:
Correlation between circulating dephosphorylated uncarboxylated
matrix Gla protein and vascular calcification in peritoneal
dialysis patients. Int J Artif Organs. 47:885–893. 2024.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Nyvad J, Christensen KL, Andersen G,
Reinhard M, Nørgaard BL, Madsen JS, Nielsen S, Thomsen MB, Jensen
JM, Peters CD and Buus NH: PIVKA-II but not dp-ucMGP is associated
with aortic calcification in chronic kidney disease. BMC Nephrol.
25(426)2024.PubMed/NCBI View Article : Google Scholar
|
